semaglutide poisoning approval boosts GLP-1 poison center reports Poison centers across the U.S.

GLP-1 prescriptions

In the prescribing information, the tablet dosing schedule steps up from 1.5 mg 4 mg 9 mg 25 mg over time to help tolerability

Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, et al

Planned combinations include: ASC35 + ASC36: GLP-1R/GIPR dual agonist + amylin receptor agonist ASC35 + ASC47: GLP-1R/GIPR dual agonist + THR agonist for adipose targeting Both ASC36 and ASC47 are once-monthly injectable peptides developed on the ULAP platform

This once-weekly injection enhances your weight loss journey when combined with a healthy diet and exercise

Hard work Individually, we organize and prioritize our case responsibilities and focus on getting them completed quickly and efficiently